Forskohlii (Coleus forskohlii)
Specifically for Glaucoma
0 up • 0 down
Why it works for Glaucoma:
Mechanism (cAMP → lower IOP): Forskolin directly stimulates adenylyl cyclase, increasing cAMP in ciliary epithelium and trabecular meshwork. Human and animal experiments show this reduces aqueous humor inflow (and possibly relaxes outflow tissues), lowering IOP. The Lancet
What that means in the eye: Classic human studies found that a single topical dose of 1% forskolin decreased IOP and reduced aqueous flow by ~34% without changing outflow facility—consistent with less fluid being produced. The Lancet
Broader rationale: Recent reviews summarize the same cAMP-mediated actions (reduced inflow; relaxation of ciliary/trabecular tissues). Some formulations explore antioxidant/neuroprotective co-ingredients, but IOP lowering remains the main, most consistent effect. MDPI
How to use for Glaucoma:
Topical (eye-drop) forskolin
- Concentration used: 1% suspension/solution in clinical and volunteer studies. Effects appear within 1–2 hours and last roughly 4–6 hours after a dose, implying that multiple daily doses would be required for sustained pressure control. The Lancet
- Regimens seen in trials: Randomized and crossover trials used two drops of 1% at dosing visits and compared against timolol/placebo; IOP reduction was typically a few mmHg over hours. (Note: these publications vary in quality; see “Evidence” below.) Europe PMC
- Practical cautions: No widely approved ophthalmic forskolin product exists in many countries, so compounding/quality control is a concern. If considered, it should be adjunctive and monitored with standard tonometry/field testing by your ophthalmologist. MDPI
Oral combinations (adjunct to drops)
- Formulation & dose used in studies: A small open-label study added one tablet daily containing 150 mg Coleus forskohlii extract (10% forskolin → 15 mg forskolin) + rutin 200 mg + vitamins B1/B2 for 40 days in patients already on maximal topical therapy; average IOP fell further (~20% from baseline) and returned toward baseline after stopping. Another clinical series explored forskolin + rutin with similar adjunctive findings and some improvement in PERG (a retinal function measure). La Clinica Terapeutica
- Context: These are adjunct nutraceutical studies; products and doses differ by manufacturer, and results shouldn’t be generalized to all supplements. Europe PMC
Scientific Evidence for Glaucoma:
Foundational physiology / early clinical
- Lancet (1983): In rabbits, monkeys, and healthy volunteers, topical 1% forskolin lowered IOP within 1 hour. The Lancet
- Experimental Eye Research (1984): In human subjects who responded to 1% forskolin, aqueous humor flow decreased ~34%, with IOP reduction—mechanistic confirmation. ScienceDirect+1
Patient-oriented trials
Topical 1% drops—randomized/controlled: A frequently cited randomized, double-blind study (open-access PDF available) compared 1% forskolin with timolol/placebo and reported statistically significant IOP lowering over hours; methodology and publisher quality (OMICS) are debated, so interpret cautiously. ResearchGate
Open-label/summary reports: A 2015 article reviews 1% forskolin drops, noting peak IOP reduction around 6 hours post-instillation in crossover work; again, this is a narrative review of small/older trials. ScienceDirect
Oral adjuncts (forskolin + rutin ± B-vitamins):
- Clinica Terapeutica (2010): 16 POAG patients on topical therapy took 15 mg/day forskolin (as 10% extract) + rutin 200 mg + B1/B2 for 40 days → ~20% IOP reduction, effect reversed after stopping. Open-label, small sample. La Clinica Terapeutica
- Further clinical reports (PERG + IOP): A later paper reported IOP reduction and PERG signal improvement with a similar combo; details are consistent with an adjunct (not replacement) effect. jscimedcentral.com
ClinicalTrials.gov entry: Records planned evaluation of topical forskolin in glaucoma patients; useful for protocol context and mechanism summary. Clinical Trials
Recent narrative/umbrella reviews: Summarize that forskolin can lower IOP, but high-quality, long-term, head-to-head trials versus modern first-line agents are lacking. MDPI
Specific Warnings for Glaucoma:
Not a stand-alone or proven disease-modifier: Evidence is insufficient to use forskolin instead of standard therapy. Always continue your prescribed drops unless your ophthalmologist tells you otherwise. MDPI
Blood pressure & heart effects: Forskolin can lower blood pressure; use caution if you have hypotension, are on antihypertensives, nitrates, or PDE-5 inhibitors. Memorial Sloan Kettering Cancer Center
Bleeding risk & drug interactions: Lab/clinical sources flag antiplatelet/anticoagulant interaction potential (e.g., warfarin, DOACs, aspirin, clopidogrel). People with bleeding disorders or on blood thinners should avoid or get explicit medical clearance. Memorial Sloan Kettering Cancer Center
Pregnancy & breastfeeding: Insufficient safety data—avoid unless specifically advised by a clinician. WebMD
GI and local ocular side-effects: Oral use can cause GI upset; topical drops may sting/burn or cause conjunctival hyperemia like many glaucoma drops. Stop and seek care for significant symptoms. ScienceDirect
Product quality: Supplements/compounded drops can vary in potency and purity; choose reputable, quality-assured sources and coordinate prescribing/compounding through your ophthalmologist. MDPI
General Information (All Ailments)
What It Is
Coleus forskohlii—commonly known simply as Forskohlii—is a perennial plant belonging to the mint family (Lamiaceae), native to subtropical and tropical regions of India, Nepal, and Thailand. The root of this plant contains a biologically active compound called forskolin, which is primarily responsible for its health-related properties. Forskolin has been used for centuries in traditional Ayurvedic medicine to treat various ailments, including respiratory disorders, cardiovascular conditions, and digestive issues.
Today, Forskohlii supplements are marketed for a wide range of uses, particularly in weight management, metabolic support, and cardiovascular health. The root extract is usually standardized to a specific forskolin concentration (commonly 10–20%) and consumed as a capsule or powder.
How It Works
The key mechanism of forskolin lies in its ability to activate the enzyme adenylate cyclase, which increases cyclic adenosine monophosphate (cAMP) levels in cells. cAMP is an important signaling molecule that regulates many physiological processes. By elevating intracellular cAMP, forskolin influences multiple systems in the body:
- Metabolic Effects: Increased cAMP stimulates enzymes that help release fatty acids from body tissues, promoting lipolysis (fat breakdown). This is why forskolin is often studied in the context of body composition and weight loss.
- Cardiovascular Effects: Elevated cAMP in heart muscle cells can enhance heart contractility and improve blood flow by relaxing vascular smooth muscles. This can contribute to mild vasodilation and reduced blood pressure.
- Respiratory Effects: Forskolin’s bronchodilatory action, also mediated by cAMP, helps relax airway muscles, potentially benefiting people with asthma or bronchial conditions.
- Thyroid and Hormonal Influence: cAMP plays a role in the regulation of thyroid hormones and certain endocrine pathways, which can influence energy metabolism.
Essentially, forskolin acts as a natural activator of cellular energy processes, improving signal transmission between hormones and cells without directly mimicking those hormones.
Why It’s Important
Forskolin has attracted scientific interest because of its broad biological effects related to cellular signaling and metabolism. While the evidence is still evolving, its importance lies in several potential therapeutic and health-supporting roles:
- Weight Management: Some small studies suggest forskolin supplementation may help preserve lean body mass and reduce body fat in overweight individuals by enhancing lipolysis and metabolic rate.
- Cardiovascular Support: By promoting vasodilation and improving myocardial function, forskolin may support blood pressure regulation and circulation.
- Respiratory Health: Forskolin’s ability to relax bronchial muscles has led to its investigation as an adjunct in asthma management.
- Research Tool: In scientific research, forskolin is a valuable compound used to study cAMP-dependent cellular pathways, which are fundamental to many biological and pharmacological studies.
Although forskolin’s health benefits are promising, clinical evidence in humans remains limited and inconsistent, emphasizing the need for further controlled research.
Considerations
Before using Forskohlii or forskolin supplements, several important considerations should be taken into account:
- Efficacy: While early results are encouraging, most studies have small sample sizes or short durations. The magnitude of forskolin’s effects on fat loss or metabolic enhancement is modest and not guaranteed.
- Safety and Side Effects: Forskolin may cause side effects such as low blood pressure, increased heart rate, or gastrointestinal discomfort. Because it acts as a vasodilator and can affect cardiac contractility, it may not be suitable for individuals with certain cardiovascular conditions.
- Drug Interactions: It may interact with antihypertensive medications, anticoagulants, and antiplatelet drugs, increasing risks of hypotension or bleeding. Consultation with a healthcare professional is essential before combining it with other therapies.
- Supplement Quality: Not all forskolin supplements are standardized or pure. Choosing products with verified forskolin concentrations and third-party testing helps ensure safety and effectiveness.
- Pregnancy and Medical Conditions: There is insufficient data on forskolin use during pregnancy or in individuals with liver, kidney, or endocrine disorders, so use should be avoided or medically supervised.
Helps with these conditions
Forskohlii (Coleus forskohlii) is most effective for general wellness support with emerging research . The effectiveness varies by condition based on clinical evidence and user experiences.
Detailed Information by Condition
High Blood Pressure
Proposed mechanism: Forskolin directly activates adenylate cyclase → raises intracellular cAMP → relaxes vascular smooth muscle via downstream signali...
Asthma
Direct adenylate cyclase activator → ↑ cAMP. Forskolin directly activates adenylate cyclase (independent of β-receptors), raising intracellular cAMP....
Glaucoma
Mechanism (cAMP → lower IOP): Forskolin directly stimulates adenylyl cyclase, increasing cAMP in ciliary epithelium and trabecular meshwork. Human and...
Community Discussion
Share results, tips, and questions about Forskohlii (Coleus forskohlii).
Loading discussion...
No comments yet. Be the first to start the conversation!
Discussion for Glaucoma
Talk specifically about using Forskohlii (Coleus forskohlii) for Glaucoma.
Loading discussion...
No comments yet. Be the first to start the conversation!
Remedy Statistics
Helps With These Conditions
Recommended Products
No recommended products added yet.